Ignite Creation Date:
2024-05-06 @ 4:49 PM
Last Modification Date:
2024-10-26 @ 2:16 PM
Study NCT ID:
NCT05101616
Status:
SUSPENDED
Last Update Posted:
2024-03-07
First Post:
2021-10-28
Brief Title:
A Pilot Study of Neoadjuvant Chemotherapy With or Without Camrelizumab for Locally Advanced Gastric Cancer
Sponsor:
Shanghai Minimally Invasive Surgery Center
Organization:
Shanghai Minimally Invasive Surgery Center
Organization Data
Organization:
Shanghai Minimally Invasive Surgery Center
Class:
OTHER
Study ID:
Camrelizumab-GC-neoadjuvant
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai Minimally Invasive Surgery Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None